Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00634556 · ClinicalTrials.gov registry record · Phase 1
Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 49
- Enrollment target
NCT00634556 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 49 participants.
The verdict
NCT00634556, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 49 participants
- Enrollment target
Study Summary
Dr. Kevin J. Black at Washington University is conducting a study to learn whether we can use MRI scans to test dopamine function in the brain and to determine whether the brain performs memory tasks differently in Tourette Syndrome (TS). TS is a movement disorder characterized by vocal tics (sounds) and motor tics (movements). We will measure how and where brain activity changes using magnetic resonance imaging (MRI) scans during memory tasks and after taking levodopa. Levodopa is a drug commonly used for the treatment of Parkinson's disease (PD), a very different movement disorder.
Interventions
- DRUG placebo
- DRUG levodopa solution 2mg/ml for i.v. use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2006-02 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00634556
The ClinicalTrials.gov registry entry for NCT00634556 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00634556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00634556 about?
NCT00634556 is a clinical study titled "Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)". Dr. Kevin J. Black at Washington University is conducting a study to learn whether we can use MRI scans to test dopamine function in the brain and to determine whether the brain performs memory tasks differently in Tourette Syndrome (TS). TS is a movement disorder characterized by vocal tics (sounds...
What is the current status of trial NCT00634556?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 49 participants. The study started on 2006-02. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00634556?
The interventions under investigation include: placebo (DRUG), levodopa solution 2mg/ml for i.v. use (DRUG).
Who is sponsoring clinical trial NCT00634556?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.